Develops oral small-molecule antagonists of the bradykinin B2 receptor, including deucrictibant, to treat and prevent hereditary angioedema (HAE) attacks.
Pharvaris
Details
- LSH Companies
Emmy Noetherweg 2, 2333 BK, Leiden
Develops oral small-molecule antagonists of the bradykinin B2 receptor, including deucrictibant, to treat and prevent hereditary angioedema (HAE) attacks.
Emmy Noetherweg 2, 2333 BK, Leiden